peppermint water
PreclinicalSmall molecule
peppermint water is one of 7 small molecule programs targeting Breast. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Breast
#DrugCompanyPhaseTrials
1Cyklokapron
JJ Molner
Approved
Lynparza
AstraZenecaPhase 2
Prolia
OOrganon and Co
Phase 2
Calcium
Eli LillyPhase 2
Spectracef
Jazz PharmaceuticalsPreclinical
Intranasal Breast Milk
SSemmelweis University
Phase 1
peppermint water
TTabriz University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for peppermint water. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- TTabriz University